Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Eyes Help For Makers Hurt By Shortage Of Chinese Bulks

This article was originally published in PharmAsia News

Executive Summary

The Indian government could come to the rescue of bulk makers that have suffered by China's interim closure of several plants to avoid pollution problems during the Olympic games. Nearly 50 bulk drug makers in India have shut down and others have suspended manufacturing activities because of the shortage of raw materials. The Chinese restrictions have led to higher prices for Indian bulk makers, so the Indian government is inspecting clusters of those firms to check on the impact of the shortage. Industry observers, however, already see bulk prices declining in anticipation of resumption of Chinese manufacturing at the end of the Olympics. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts